9 Anemia Clinical Trials in Bethesda, MD (2026)

Q: How do I join a clinical trial in Bethesda?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you.

Recruiting Anemia Studies in Bethesda

NCT00027274Recruiting

Cancer in Inherited Bone Marrow Failure Syndromes

Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Pathogenic variant(s) in IBMFS ge...

Bethesda, MD4,000 participantsNational Cancer Institute (NCI)

View Study Details

NCT05012111Recruiting

Natural History of Acquired and Inherited Bone Marrow Failure Syndromes

Background: Bone marrow failure diseases are rare. Much is known about the diseases at the time of diagnosis, but long-term data about the effects of the diseases and treatments are lacking. Research...

Bethesda, MD1,000 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT05687149Recruiting

Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia

Background: Fanconi anemia (FA) is an inherited disorder. People with FA are more likely to get certain cancers, especially squamous cell carcinoma (SCC). These cancers usually appear first in the mo...

Bethesda, MD200 participantsNational Cancer Institute (NCI)

View Study Details

NCT01174108Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

Background: * Stem cell transplants from related donors (allogenic stem cell transplants) can be used to treat individuals with certain kinds of severe blood diseases or cancers, such as severe anemi...

Bethesda, MD120 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT04304820Recruiting

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Background: Severe aplastic anemia (SAA) is a rare and serious blood disorder. It causes the immune system to turn against bone marrow cells. Standard treatment for SSA is a combination of 3 drugs (C...

Bethesda, MD80 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT03520647Recruiting

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Background: Severe aplastic anemia (SAA), and myelodysplastic syndrome (MDS), and paroxysmal nocturnal hemoglobinuria (PNH) cause serious blood problems. Stem cell transplants using bone marrow or b...

Bethesda, MD56 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT03173937Recruiting

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

Background: Severe aplastic anemia (SAA) and myelodysplastic syndrome (MDS) are bone marrow diseases. People with these diseases usually need a bone marrow transplant. Researchers are testing ways to...

Bethesda, MD37 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT07566494Recruiting

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

Background: Sickle cell disease (SCD) is an inherited blood disorder. The disease affects the ability of red blood cells to carry oxygen. Research has shown that curcumin, a natural compound found in...

Bethesda, MD25 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT06744283Recruiting

Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia

Background: Fanconi anemia (FA) is a rare, inherited cancer syndrome. FA causes a range of physical issues. Children with FA may have abnormal features; these may include a small head and eyes and is...

Bethesda, MD20 participantsNational Cancer Institute (NCI)

View Study Details

About Anemia Clinical Trials in Bethesda

Anemia is a condition in which the blood lacks adequate healthy red blood cells to carry sufficient oxygen to tissues. Iron deficiency is the most common cause, affecting over 1.6 billion people worldwide. Treatment depends on the cause and may include iron supplementation, B12, or treating underlying conditions.

There are currently 9 anemia clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 5,538 participants. Research is being sponsored by National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Anemia Clinical Trials in Bethesda — FAQ

Are there anemia clinical trials in Bethesda?

Yes, there are 9 anemia clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What anemia treatments are being tested?

The 9 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for anemia.

Data updated July 13, 2026 from ClinicalTrials.gov